The definition of landmark studies attributed to the two studies published in Science that report the results obtained at the Milan TIGET, respectively on metachromatic leukodystrophy and the Wiskott Aldrich syndrome, is not a daring exaggeration. Indeed, for the first time we may speak of an effective treatment against two diseases which, until now,